Allergic Disease - High Risk Infant

This paper reports the results of the Learning Early about Peanut Allergy (LEAP) trial. This open-label, single site randomized control trial was initiated to determine which strategy is the most effective in preventing the development of peanut allergy in infants at high risk for allergy. The researchers compared exposing infants to peanut (at least 6 g of peanut protein per week) to restricting their exposure to peanut (peanut avoidance until 60 months of age). The infants, who